Sartorius Stedim Biotech (CHIX:DIMP) Other Current Liabilities : €470 Mil (As of Mar. 2025)

View and export this data going back to 2012. Start your Free Trial

What is Sartorius Stedim Biotech Other Current Liabilities?

Sartorius Stedim Biotech's other current liabilities for the quarter that ended in Mar. 2025 was €470 Mil.

Sartorius Stedim Biotech's quarterly other current liabilities increased from Sep. 2024 (€395 Mil) to Dec. 2024 (€441 Mil) and increased from Dec. 2024 (€441 Mil) to Mar. 2025 (€470 Mil).

Sartorius Stedim Biotech's annual other current liabilities declined from Dec. 2022 (€551 Mil) to Dec. 2023 (€410 Mil) but then increased from Dec. 2023 (€410 Mil) to Dec. 2024 (€441 Mil).

Sartorius Stedim Biotech Other Current Liabilities Historical Data

The historical data trend for Sartorius Stedim Biotech's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius Stedim Biotech Other Current Liabilities Chart

Sartorius Stedim Biotech Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Current Liabilities

Get a 7-Day Free Trial

297.60

580.40

550.70

410.30

441.00

Sartorius Stedim Biotech Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Current Liabilities	Get a 7-Day Free Trial															328.90	379.00	394.60	441.00	470.20

Sartorius Stedim Biotech Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Sartorius Stedim Biotech Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Sartorius Stedim Biotech's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Sartorius Stedim Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (CHIX:DIMp) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

SRTOY:USA SDMHF:USA 0RG8:UK DIM:France 56S1:Germany DIM:Austria

Address

Otto-Brenner-Strasse 20, Goettingen, DEU, 37079

Website

https://www.sartorius.com

Sartorius Stedim Biotech is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs and has a focus on single-use technology. It is a subsidiary of Sartorius AG, which has 71.5% ownership and 83% voting control. The business is geographically diverse, with 35% of sales from the Americas, 42% from Europe, the Middle East, and Africa, 15% from Asia excluding China, and 8% from China.

Sartorius Stedim Biotech Headlines

No Headlines